AN OPEN LABEL EXTENSION STUDY OF BRENTUXIMAB VEDOTIN TREATMENT IN ACTIVE DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DIFFUSE SCLERODERMA)
- Registry ID
- BV202108
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Study type
- INTERVENTIONAL
- Sponsor
- ST JOSEPHS HEALTH CENTRE LONDON
- Last update
- 2021-10-13
Conditions
- DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
View on source registry